Litigation Details for Adamis Pharmaceuticals Corporation v. Belcher Pharmaceuticals, LLC (M.D. Fla. 2018)
✉ Email this page to a colleague
Adamis Pharmaceuticals Corporation v. Belcher Pharmaceuticals, LLC (M.D. Fla. 2018)
| Docket | ⤷ Sign Up | Date Filed | 2018-09-26 |
| Court | District Court, M.D. Florida | Date Terminated | 2019-07-29 |
| Cause | 15:1126 Patent Infringement | Assigned To | William F. Ju |
| Jury Demand | Defendant | Referred To | Amanda Arnold Sanson |
| Patents | 10,004,700; 9,283,197 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Adamis Pharmaceuticals Corporation v. Belcher Pharmaceuticals, LLC
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Adamis Pharmaceuticals Corporation v. Belcher Pharmaceuticals, LLC (M.D. Fla. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2018-09-26 | 1 | of U.S. Patent Nos. 9,283,197 (“’197 Patent”) and 10,004,700 (“’700 Patent”) under the patent laws of… The ’197 Patent 11. The ’197 patent, entitled “More Potent and Less…purports to be the assignee of the ’197 Patent. A copy of the ’197 Patent is attached hereto as Exhibit A. … ’197 Patent at 4:48-59. 13. While prosecuting the ’197 Patent application, the…the ’197 patent require an in-process pH between 2.8 and 3.3. Claims 1-5 of the ’197 patent further require | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
